Login / Signup

Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trials.

Jessica Mejía-CastrejónJuan Gerardo Sierra-MaderoPablo Francisco Belaunzarán-ZamudioAna Fresán-OrellanaAlejandro Molina-LopezAtenea Betzabé Álvarez-MotaRebeca Robles García
Published in: Psychotherapy research : journal of the Society for Psychotherapy Research (2023)
ClinicalTrials.gov identifier: NCT03878186.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • phase iii